Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INCCCEL · Entity 7400 | Chief Information Officer | January 07, 2026 | January 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CRYO CELL INTERNATIONAL INC
Report date January 07, 2026 · Filed January 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.54 · Expires 2031-01-07 | Direct | 10,000 |
Reported balance
After 2026-01-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-01-07 · Grant · Acquired 10,000 · Balance 10,000 F5: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.54 · Expires 2031-01-07 | Direct | 20,000 |
Reported balance
After 2026-01-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-01-07 · Grant · Acquired 20,000 · Balance 20,000 F6: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.49 · Expires 2028-05-21 | Direct | 8,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 8,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.13 · Expires 2029-09-04 | Direct | 4,444 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 4,444 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.55 · Expires 2030-02-27 | Direct | 1,333 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 1,333 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.00 · Expires 2028-09-23 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 10,000 F1: Stock options vest 1/5 per year commencing on September 23, 2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $11.90 · Expires 2028-12-28 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 20,000 F2: Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven year option period. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $5.88 · Expires 2028-12-22 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 10,000 F3: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.35 · Expires 2030-01-21 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 10,000 F4: Stock options vest 1/3 upon issuance, 1/3 on January 22, 2026 and 1/3 on January 22, 2027. |
| Common StockSEC Table I · non-derivative | Direct | 104,349 |
Reported balance
Holding disclosure · report date 2026-01-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 104,349 |
Filing footnotes · ownership attribution and instrument terms
F1: Stock options vest 1/5 per year commencing on September 23, 2021.
F2: Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven year option period.
F3: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
F4: Stock options vest 1/3 upon issuance, 1/3 on January 22, 2026 and 1/3 on January 22, 2027.
F5: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028.
F6: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 20,000 | $3.54 Strike: $3.54 | $70,800.00 |
DisclosureSEC source: 0001193125-26-009069 · ownership.xml · derivative · entry 10 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-01-07 F6 · derivative.exercise_date: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 10,000 | $3.54 Strike: $3.54 | $35,400.00 |
DisclosureSEC source: 0001193125-26-009069 · ownership.xml · derivative · entry 9 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-01-07 F5 · derivative.exercise_date: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 10,000 | $7.35 Strike: $7.35 | $73,500.00 |
DisclosureSEC source: 0000950170-25-008397 · ownership.xml · derivative · entry 8 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-01-21 F4 · derivative.exercise_date: Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 22:15 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 10,000 | $4.34 Strike: $4.34 | $43,400.00 |
DisclosureSEC source: 0000950170-24-127202 · ownership.xml · derivative · entry 5 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2028-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 22:15 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 10,000 | $3.20 Strike: $3.20 | $32,000.00 |
DisclosureSEC source: 0000950170-24-127202 · ownership.xml · derivative · entry 4 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Commpn Stock · 10,000 shares Expires 2026-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 22:15 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 10,000 | $4.34 | $43,400.00 |
DisclosureSEC source: 0000950170-24-127202 · ownership.xml · nonDerivative · entry 3 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 22:15 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 10,000 | $3.20 | $32,000.00 |
DisclosureSEC source: 0000950170-24-127202 · ownership.xml · nonDerivative · entry 2 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2023 Filed Dec 28, 2023 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 10,000 | $5.88 Strike: $5.88 | $58,800.00 |
DisclosureSEC source: 0001209191-23-059920 · doc4.xml · derivative · entry 9 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-12-22 F4 · derivative.exercise_date: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 10,000 | $4.34 Strike: $4.34 | $43,400.00 |
DisclosureSEC source: 0001209191-23-001953 · doc4.xml · derivative · entry 8 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-01-03 F5 · derivative.exercise_date: Stock options fully vest upon issuance. Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 20,000 | $3.20 Strike: $3.20 | $64,000.00 |
DisclosureSEC source: 0001209191-22-047884 · doc4.xml · derivative · entry 2 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 20,000 shares Expires 2026-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 20,000 | $3.20 | $64,000.00 |
DisclosureSEC source: 0001209191-22-047884 · doc4.xml · nonDerivative · entry 1 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2021 Filed Dec 28, 2021 21:32 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 10,000 | $3.20 Strike: $3.20 | $32,000.00 |
DisclosureSEC source: 0001209191-21-071380 · doc4.xml · derivative · entry 3 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2026-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2021 Filed Dec 28, 2021 21:32 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 10,000 | $3.20 | $32,000.00 |
DisclosureSEC source: 0001209191-21-071380 · doc4.xml · nonDerivative · entry 2 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 20,000 | $11.90 Strike: $11.90 | $238,000.00 |
DisclosureSEC source: 0001209191-21-071484 · doc4.xml · derivative · entry 7 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-12-02 F4 · derivative.exercise_date: Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term. Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 22:24 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 10,000 | $8.00 Strike: $8.00 | $80,000.00 |
DisclosureSEC source: 0001209191-20-052131 · doc4.xml · derivative · entry 6 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-09-23 F3 · derivative.exercise_date: Stock options vest at a rate of 1/5 per year commencing on September 23, 2021. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:10 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Options · Derivative | 1,333 | $6.55 Strike: $6.55 | $8,731.15 |
DisclosureSEC source: 0000899243-20-006534 · doc4.xml · derivative · entry 4 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,333 Underlying: Common Stock · 1,333 shares Expires 2030-02-27 F4 · derivative.exercise_date: Stock options will vest 1/3 upon date of grant, 1/3 on December 1, 2020 and 1/3 on November 30, 2021. Read SEC document |
| December 23, 2019 Filed Jan 13, 2020 21:18 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Options · Derivative | 20,000 | $2.05 Strike: $2.05 | $41,000.00 |
DisclosureSEC source: 0000899243-20-001060 · doc4.xml · derivative · entry 4 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2019 Filed Jan 13, 2020 21:18 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 20,000 | $2.05 | $41,000.00 |
DisclosureSEC source: 0000899243-20-001060 · doc4.xml · nonDerivative · entry 3 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2019 Filed Mar 2, 2020 22:10 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 20,000 | $2.05 | $41,000.00 |
DisclosureSEC source: 0000899243-20-006534 · doc4.xml · nonDerivative · entry 3 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2019 Filed Jan 13, 2020 21:18 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 5,000 | $8.08 | $40,400.00 |
DisclosureSEC source: 0000899243-20-001060 · doc4.xml · nonDerivative · entry 2 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,349 F1 · shares: Shares of restricted stock awarded per the December 1, 2015 Employment Agreement. The shares were issued on December 3, 2019 as a result the ratification of stock issuances and equity awards at the Company's annual meeting on November 21, 2019. Read SEC document |
| December 03, 2019 Filed Jan 13, 2020 21:18 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 9,729 | $4.15 | $40,375.35 |
DisclosureSEC source: 0000899243-20-001060 · doc4.xml · nonDerivative · entry 1 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,349 F1 · shares: Shares of restricted stock awarded per the December 1, 2015 Employment Agreement. The shares were issued on December 3, 2019 as a result the ratification of stock issuances and equity awards at the Company's annual meeting on November 21, 2019. Read SEC document |
| December 03, 2019 Filed Mar 2, 2020 22:10 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 5,000 | $8.08 | $40,400.00 |
DisclosureSEC source: 0000899243-20-006534 · doc4.xml · nonDerivative · entry 2 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,349 F1 · shares: Shares of restricted stock awarded per the December 1, 2015 Employment Agreement. The shares were issued on December 3, 2019 as a result the ratification of stock issuances and equity awards at the Company's annual meeting on November 21, 2019. Read SEC document |
| December 03, 2019 Filed Mar 2, 2020 22:10 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 9,729 | $4.15 | $40,375.35 |
DisclosureSEC source: 0000899243-20-006534 · doc4.xml · nonDerivative · entry 1 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,349 F1 · shares: Shares of restricted stock awarded per the December 1, 2015 Employment Agreement. The shares were issued on December 3, 2019 as a result the ratification of stock issuances and equity awards at the Company's annual meeting on November 21, 2019. Read SEC document |
| September 04, 2019 Filed Sep 4, 2019 21:35 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 4,444 | $7.13 Strike: $7.13 | $31,685.72 |
DisclosureSEC source: 0000899243-19-022754 · doc4.xml · derivative · entry 5 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,444 Underlying: Common Stock · 4,444 shares Expires 2029-09-04 F3 · derivative.exercise_date: Stock options will vest 1/3 upon date of grant, 1/3 on December 1, 2019 and 1/3 on November 30, 2020. F3 · derivative.expiration_date: Stock options will vest 1/3 upon date of grant, 1/3 on December 1, 2019 and 1/3 on November 30, 2020. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 19,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-006701 · doc4.xml · nonDerivative · entry 2 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,620 F1 · shares: Shares of restricted stock awarded for 2016 performance pursuant to employment agreement executed April 15, 2016. Read SEC document |
| March 03, 2017 Filed May 22, 2018 20:15 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 19,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-013683 · doc4.xml · nonDerivative · entry 1 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,620 F1 · shares: Shares of restricted stock awarded for 2016 performance pursuant to employment agreement executed April 15, 2016. Read SEC document |
| March 03, 2017 Filed Sep 4, 2019 21:35 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 19,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-022754 · doc4.xml · nonDerivative · entry 1 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,620 F1 · shares: Shares of restricted stock awarded for 2016 performance pursuant to employment agreement executed April 15, 2016. Read SEC document |
| August 06, 2015 Filed Mar 7, 2017 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 20,000 | $3.25 | $65,000.00 |
DisclosureSEC source: 0000899243-17-006701 · doc4.xml · nonDerivative · entry 1 Mikulinsky Oleg · CIK 0001544572 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.